Hyper- and Hypoaldosteronism

Vitamins and Hormones

Volumn 57, Issue C, 1997, Pages 177-216

  Torpy, David J ^a   Stratakis, Constantine A ^a   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR;

ADOLESCENT; ADULT; ANIMAL; BIOSYNTHESIS; CHILD; CLASSIFICATION; HUMAN; HYPERALDOSTERONISM; HYPOALDOSTERONISM; INFANT; NEWBORN; PATHOPHYSIOLOGY; REVIEW; SECRETION;

ADOLESCENT; ADULT; ALDOSTERONE; ANIMALS; CHILD; HUMANS; HYPERALDOSTERONISM; HYPOALDOSTERONISM; INFANT; INFANT, NEWBORN; RECEPTORS, ALDOSTERONE;

EID: 0032612072     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60644-5     Document Type: Article

References (156)

1. Abdelhamid S., Muller-Lobeck H., Pahl S., Remberger K., Bonhof J.A., Walb D., and Rockel A. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. Arch. Intern. Med. 156 (1996) 1190-1195
2. Batlle D.C., Hizon M., Cohen E., Gutterman C., and Gupta R. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N. Eng. J. Med. 318 (1988) 594-599
3. Beckers A., Abs R., and Willems P.J. Aldosterone secreting adenoma as part of multiple endocrine neoplasia type I (MEN I): Loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN I locus. J. Clin. Endocrinol. Metab. 75 (1992) 564-570
4. Biglieri E.G., Slaton Jr. P.E., Silen W.S., Galante M., and Forsham P.H. Postoperative studies of adrenal function in primary aldosteronism. J. Clin. Endocrinol. Metab. 26 (1996) 553-558
5. Biglieri E.G. Primary aldosteronism. Curr. Ther. Endocrinol. Metab. 6 (1997) 170-172
6. Blair-West J.R., Coghlan J.P., Denton D.A., Fei D.T., Hardy K.J., Scoggins B.A., and Wright R.D. A dose-response comparison of the actions of angiotensin II and angiotensin III in sheep. J. Endocrinol. 87 (1980) 409-417
7. Bliddal J., and Nielsen I. Renin, aldosterone and electrolytes in idiopathic orthostatic hypotension. Dan. Med. Bull. 17 (1970) 153-157
8. Blumenfeld J.D., Sealey J.E., Schlussel Y., Vaughan Jr. E.D., Sos T.A., Atlas S.A., Muller F.B., Acevedo R., Ulick S., and Laragh J.H. Diagnosis and treatment of primary hyperaldosteronism. Ann. Intern. Med. 121 (1994) 877-885
9. Boscaro M., Betterle C., Volpato M., Fallo F., Furmaniak J., Smith R.B., and Sonino N. Hormonal responses during various phases of autoimmune adrenal failure: No evidence for 21-hydroxylase enzyme activity inhibition in vivo. J. Clin. Endocrinol. Metab. 81 (1996) 2801-2804
10. Bravo E.L., Turazi R.C., and Dustan H.P. The changing clinical spectrum of primary aldosteronism. Am. J. Med. 74 (1983) 641-651
11. Brown J.J., Davies D.L., and Lever A.F. Variations in plasma renin concentration in several physiological and pathological states. Can. Med. Assoc. J. 90 (1964) 201-206
12. Campbell S.E., Diaz-Arias A.A., and Weber K.T. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1 (1992) 149-156
13. Campbell S.E., Janicki J.S., Matsubara B.B., and Weber K.T. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride. Am. J. Hypertens. 6 (1993) 487-495
14. Cantin M., and Genest J. The heart and atrial natriuretic factor. Endocr. Rev. 6 (1985) 107-127
15. Carey R.M. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin. J. Clin. Endocrinol. Metab. 54 (1982) 463-469
16. Chang S.S., Grunder S., Hanukoglu A., Mathew R.A., Hanukoglu P.M.I., Schild L., Lu Y., Shimkets R.A., Nelson-Williams C., Rossier B.C., and Lifton R.P. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalemic acidosis, pseudohypoaldosteronism type I. Nat. Genet. 5 (1996) 248-253
17. Christlieb A., Munichoodappa C., and Braaten J.T. Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension. Diabetes 23 (1974) 835-840
18. Chrousos G.P., Detera-Wadleigh S., and Karl M. Syndromes of glucocorticoid resistance. Ann. Intern. Med. 119 (1993) 1113-1124
19. Clyne C.D., Zhang Y., Slutsker L., Mathis J.M., White P.C., and Rainey W.E. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol. Endocrinol. 11 (1997) 638-649
20. Conn J.W. Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 45 (1955) 3-17
21. Conn J.W., Knopf R.F., and Nesbit R.M. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am. J. Surg. 107 (1964) 159-172
22. Corry B.C., and Tuck M.L. Secondary aldosteronism. Endocrinol. Metab. Clin. North Am. 24 (1995) 511-529
23. Corvol P., Pinet F., Plouin P.F., Bruneval P., and Menard J. Renin-secreting tumors. Endocrinol. Metab. Clin. North Am. 23 (1994) 255-270
24. Curnow K.M., Tusie-Luna M.T., Pascoe L., Natarajan R., Gu J.L., Nadler J.L., and White P.C. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol. Endocrinol. 5 (1991) 1513-1522
25. Davenport M.W., and Zipser R.D. Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient. Arch. Intern. Med. 143 (1983) 735-737
26. Davis J.O., and Freeman R.H. Mechanisms regulating renin release. Physiol. Rev. 56 (1976) 1-56
27. deFronzo R.A. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 17 (1980) 118-134
28. Doppman J.L., and Gill Jr. J.R. Hyperaldosteronism: Sampling the adrenal veins. Radiology 198 (1996) 309-312
29. el-Deiry S.S., Naidu S.S., Blevins L.S., and Ladenson P.W. Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J. Clin. Endocrinol. Metab. 82 (1997) 856-860
30. Falorni A., Nikoshkov A., Laureti S., Grenback E., Hulting A.L., Casucci G., Santeusanio F., Brunetti P., Luthman H., and Lernmark A. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against 21-hydroxylase. J. Clin. Endocrinol. Metab. 80 (1995) 2752-2755
31. Fernandez-Cruz A., North R.H., Lassman M.N., Hollis J.B., and Molrow P.J. Low plasma renin activity (PRA) in normotensive patients with diabetes mellitus: Relationship to neuropathy. Hypertension 3 (1981) 87-92
32. Findling J.W., Raff H., Hansson J.H., and Lifton R.P. Liddle's syndrome: Prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J. Clin. Endocrinol. Metab. 82 (1997) 1071-1074
33. Fiselier T., Derkx F., Monnens L., Van Munster P., Peer P., and Schalekamp M. The basal levels of active and inactive plasma renin concentration in infancy and childhood. Clin. Sci. 67 (1984) 383-387
34. Funder J.W. Apparent mineralocorticoid excess. Endocrinol. Metab. Clin. North Am. 24 (1995) 613-621
35. Gaillard R.C., Riondel A.M., Favrod-Coune C.A., Vallotton M.B., and Muller A.F. Aldosterone escape to chronic ACTH administration in man. Acta Endocrinol. (Copenh. 103 (1983) 116-124
36. Gates L.J., MacConnachie A.A., Lifton R.P., Hartes N.E., and Benjamin N. Variation of phenotype in patients with GRA. J. Med. Genet. 33 (1996) 25-28
37. Gaunt R. Action of adrenal steroids on electrolyte and water metabolism. In: Christy N.P. (Ed). "The Human Adrenal Cortex" (1971), Harper and Row, New York 373
38. Geley S., Kapelari K., Johrer K., Peter M., Glatzl J., Viehapper H., Schwarz S., Helmberg A., Sippell W.G., White P.C., and Kofler R. CYP11B1mutations causing congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81 (1996) 2896-2901
39. Geller D.H., Auchus R.J., Mendonca B.B., and Miller W.L. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat. Genet. 17 (1997) 201-205
40. Gordon R.D. Primary aldosteronism. J. Endocrinol. Invest. 18 (1995) 495-511
41. Gordon R.D., Bachmann A.W., Klemm S.A., Tunny T.J., Stowasser M., Storie W.J., and Rutherford J.C. An association of primary aldosteronism and adrenaline-secreting pheochromocytoma. Clin. Exp. Pharmacol. Physiol. 21 (1994) 219-222
42. Gordon R.D., Kuchel O., Liddle G.W., and Island D.P. Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J. Clin. Invest. 46 (1967) 599-605
43. Gordon R.D., Stowasser M., Klemm S.A., and Tunny T.J. Primary aldosteronism: Some genetic, morphological, and biochemical aspects of subtypes. Steroids 60 (1995) 35-41
44. Gordon R.D., Stowasser M., Tunny T.J., Klemm S.A., and Rutherford J.C. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin. Exp. Pharmacol. Physiol. 21 (1994) 315-318
45. Graham P.C., and Lindop G.B. The renin-secreting cell in polyarteritis: An immunocytochemical study. Histopathology 16 (1990) 339-345
46. Greco R.G., Carroll J.E., Morris D.J., Grekin R.J., and Melby J.C. Familial hyperaldosteronism, not suppressed by dexamethasone. J. Clin. Endocrinol. Metab. 55 (1982) 1013-1016
47. Guy R.J., Turberg Y., Davidson R.N., Finnerty G., MacGregor G.A., and Wise P.H. Mineralocorticoid deficiency in HIV infection. Br. Med. J. (1989) 496-497
48. Haab F., Duclos J.M., Guyenne T., Plouin P.F., and Corvol P. Renin secreting tumors: Diagnosis, conservative surgical approach and long-term results. J. Urol. 153 (1995) 1781-1784
49. Hambling C., Jung R.T., Gunn A., Browning M.C., and Bartlett W.A. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin. Endocrinol. (Oxf. 36 (1992) 499-503
50. Hansson J.H., Nelson-Williams C., Suzuki H., Schild L., Shimkets R., Lu Y., Canessa C., Iwasaki T., Rossier B., and Lifton R.P. Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of Liddle syndrome. Nat. Genet. 11 (1995) 76-82
51. HiguchiNawata K., Kato H.K., Ibayashi H., and Matsuo H. α-Human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells. J. Clin. Endocrinol. Metab. 62 (1986) 941-944
52. Hinson J.P., and Kapas S. Regulation of vasoactive intestinal peptide in the rat adrenal gland. 10th International Congress of Endocrinology, San Francisco (1996) 1-361 abstract
53. Hiramatsu K., Yamada T., Yukimura Y., Komiya I., Ichikawa K., Ishihara M., Nagata H., and Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch. Intern. Med. 141 (1981) 1589-1593
54. Holcombe J.H., Keenan B.S., Nichols B.L., Kirkland R.T., and Clayton G.W. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia. Pediatrics 65 (1980) 777-781
55. Holland O.B., Brown H., Kuhnert L., Fairchild C., Risk M., and Gomez-Sanchez C.E. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6 (1984) 717-723
56. Horton R., and Nadler J.L. Hypoaldosteronism. Curr. Ther. Endocrinol. Metab. 6 (1997) 164-167
57. Ignatowska-Switalska H., Chodakowska J., Januszewicz W., Feltynowski T., Adamczyk M., and Lewandowski J. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism. J. Hum. Hypertens. 11 (1997) 373-378
58. Inoue H., Nakajo M., Miyazono N., Nishida H., Ueno K., and Hokotate H. Transcatheter arterial ablation of aldosteronomas with high-concentration ethanol: Preliminary and long-term results. Am. J. Roentgenol. 168 (1997) 1241-1245
59. Iwaoka T., Umeda T., Naomi S., Inoue J., Sasaki M., Yamauchi J., and Sato T. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension. Am. J. Hypertens. 6 (1993) 899-906
60. Jacobs D.R., van der Poll J., Gabrilove J.L., and Soffer L.J. 17-α-hydroxyprogesterone, a salt-losing steroid: Relation to congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 21 (1961) 909-922
61. Jamieson A., Slutsker L., Inglis G.C., Fraser R., White P.C., and Connell J.M. Glucocorticoid suppressible hyperaldosteronism: Effects of cross-over site and parental origin of chimaeric gene on phenotypic expression. Clin. Sci. 88 (1995) 563-570
62. Janetschek G., Lhotta K., Gasser R., Finkenstedt G., Jaschke W., and Bartsch G. Adrenal-sparing laparoscopic surgery for aldosterone-producing adenoma. J. Endourol. 11 (1997) 145-148
63. Jonsson J.R., Klemm S.A., Tunny T.J., Stowasser M., and Gordon R.D. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem. Biophys. Res. Commun. 207 (1995) 565-571
64. Kalin M., Porestky L., Seres D., and Zumoff B. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am. J. Med. 82 (1987) 1035-1038
65. Kapas S., Martinez A., Cuttitta F., and Hinson J.P. Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J. Endocrinol. 156 (1998) 477-484
66. Kaplan N.M. Endocrine hypertension. "Williams' Textbook of Endocrinology,". 8th ed. (1992), Saunders, Philadelphia 707-731
67. Kem D.C., Weinberger M.H., Mayes D.M., and Nugent C.A. Saline suppression of plasma aldosterone in hypertension. Arch. Intern. Med. 128 (1971) 380-386
68. Kiley J., and Zager P. Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus. Am. J. Kidney Dis. 4 (1984) 39-43
69. Komesaroff P.A., Verity K., and Fuller P.J. Pseudohypoaldosteronism: Molecular characterization of the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 79 (1994) 27-31
70. 8-angiotensin III) in man. J. Clin. Endocrinol. Metab. 43 (1976) 940-943
71. Kuhnle U., Hinkel G.K., Akkurt H.I., and Krozowski Z. Familial pseudohypoaldosteronism: A review on the heterogeneity of the syndrome. Steroids 60 (1995) 157-160
72. Kuhnle U., Rosler A., Pareira J.A., Gunzcler P., Levine L.S., and New M.I. The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency. Acta Endocrinol. (Copenh. 102 (1983) 577-582
73. Landau R.L., and Lugibihl K. Inhibition of the sodium-retaining influence of aldosterone by progesterone. J. Clin. Endocrinol. Metab. 18 (1958) 1237-1245
74. Lee P.D.K., Patterson B.D., Hintz R.I., and Rosenfeld R.G. Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency. J. Clin. Endocrinol. Metab. 62 (1986) 225-229
75. Lenz T., Thiede H.M., Nussberger J., Atlas S.A., Distler A., and Schulte K.L. Hyperreninemia and secondary hyperaldosteronism in a patient with pheochromocytoma and von Hippel-Lindau disease. Nephron 62 (1992) 345-350
76. Lewin A., Blaufox M.D., Castle H., Entwisle G., and Langford H. Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch. Intern. Med. 145 (1985) 424-427
77. Lifton R.P., Dluhy R.G., Powers M., Rich G.M., Cook S., Ulick S., and Lalouel J.M. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355 (1992) 262-265
78. Litchfield W.R., and Dluhy R.G. Primary aldosteronism. Endocrinol. Metab. Clin. North Am. 24 (1995) 593-612
79. Litchfield W.R., Anderson B.F., Weiss R.J., Lifton R.P., and Dluhy R.G. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31 (1998) 445-450
80. Litchfield W.R., Coolidge C., Silva P., Lifton R.P., Fallo F., Williams G.H., and Dluhy R.G. Impaired potassium-stimulated aldosterone production: A possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 82 (1997) 1507-1510
81. Litchfield W.R., New M.I., Coolidge C., Lifton R.P., and Dluhy R.G. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 82 (1997) 3570-3573
82. London N., Swales J., Hollinrake K., Bell P., and Heagerty A. Familial Conn's syndrome. Postgrad. Med. J. 68 (1992) 976-977
83. Luo X., Ikeda Y., and Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77 (1994) 481-490
84. Marieb N.J., Melby J.C., and Lyall S.S. Isolated hypoaldosteronism associated with idiopathic hypoparathyroidism. Arch. Intern. Med. 134 (1974) 424-429
85. McKenna T.J., Island D.P., Nicholson W.E., and Liddle G.W. The effects of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa. Endocrinology 103 (1978) 1411-1416
86. McKenna T.J., Island D.P., Nicholson W.E., and Liddle G.W. Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells. J. Clin. Invest. 64 (1979) 287-291
87. McKenna T.J., Sequeira S.J., Heffernan A., Chambers J., and Cunningham S. Diagnosis under random conditions of all disorders of renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 73 (1991) 952-957
88. Melby J.C. Diagnosis of hyperaldosteronism. Endocrinol. Metab. Clin. North Am. 20 (1991) 247-255
89. Monnens L., Fiselier T., Bos B., and van Munster P. Hyporeninemic hypoaldosteronism in infancy. Nephron 35 (1983) 140-142
90. Montoli A., Colussi G., and Minetti L. Hypercalcemia in Addison's disease: Calciotropic hormone profile and bone histology. J. Intern. Med. 232 (1992) 535-540
91. Mulkerrin E., Epstein F.H., and Clark B.A. Aldosterone responses to hyperkalemia in healthy elderly humans. J. Am. Soc. Nephrol. 6 (1995) 1459-1462
92. Nadler J.L., Lee F.O., Hsueh W., and Horton R. Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism. N. Engl. J. Med. 314 (1986) 1015-1020
93. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., and Shimizu N. Positional cloning of the APECED gene. Nat. Genet. 17 (1997) 393-398
94. Nakamoto Y., Imai H., Hamanaka S., Yoshida K., Akihama T., and Miura A.B. IgM monoclonal gammopathy accompanied by nodular glomerulosclerosis, urine-concentrating defect, and hyporeninemic hypoaldosteronism. Am. J. Nephrol. 5 (1985) 53-58
95. Nguyen H.L.T., and Luong K.V.Q. Coexistence of primary aldosteronism and pheochromocytoma in a Vietnamese patient. The Endocrinologist 6 (1996) 490-493
96. Oates J.A., Whorton A.R., Gerkens J.F., Branch R.A., Hollifield J.W., and Frolich J.C. The participation of prostaglandins in the control of renin release. Fed. Proc. 38 (1979) 72-74
97. Oberfield S.E., Levine L.S., and Carey R.M. Pseudohypoaldosteronism: Multiple target organ unresponsiveness to mineralocorticoid hormones. J. Clin. Endocrinol. Metab. 48 (1979) 228-233
98. Oh M.S., Carroll H.J., Clemmons J.E., Vagnucci A.H., Levison S.P., and Whang E.S. A mechanisms for hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism 23 (1974) 1157-1166
99. O'Kelly R., Magee F., and McKenna T.J. Routine heparin therapy inhibits adrenal aldosterone production. J. Clin. Endocrinol. Metab. 56 (1983) 108-112
100. Orth D.N., Kovacs W.J., and DeBold C.R. The adrenal cortex. In: Wilson J.D., and Foster D.W. (Eds). "Textbook of Endocrinology" (1990), Saunders, Philadelphia 568-569
101. Oster J.R., Perez G.O., and Rosen M.S. Hyporeninemic hypoaldosteronism after chronic sodium bicarbonate abuse. Arch. Intern. Med. 136 (1976) 1179-1180
102. Pascoe L., Jeunemaitre X., Lebrethon M.C., Curnow K.M., Gomez-Sanchez C.E., Gase J.M., Saez J.M., and Corvol P. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J. Clin. Invest. 96 (1995) 2236-2246
103. Perez G.O., Lespier L., Jacobi J., Oster J.R., Katz F.H., Vaamounde C.A., and Fishman L.M. Hyporeninemic hypoaldosteronism in diabetes mellitus. Arch. Intern. Med. 137 (1977) 852-855
104. Phelps K.R., Lieberman R.L., Oh M.S., and Carroll H.J. Pathophysiology of the syndrome of hyporeninemic hypoaldosteronism. Metabolism 29 (1980) 186-199
105. Ramayya M.S., Zhou J., Kino T., Segars J.H., Bondy C.A., and Chrousos G.P. Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J. Clin. Endocrinol. Metab. 82 (1997) 1799-1806
106. Rasmussen H., and Waisman D. The messenger function of calcium in endocrine systems. In: Litwack G. (Ed). "Biochemical Action of Hormones" 8 (1970), Academic, New York 1
107. Rabinowitz D., Landau H., Rosler A., Moses S.W., Rotem Y., and Freier S. Plasma renin activity and aldosterone in familial dysautonomia. Metabolism 23 (1974) 1-5
108. Rodriguez-Soriano J., Vallo A., Castillo G., and Oliveros R. Renal handling of water and sodium in infancy and childhood: A study using clearance methods during hypotonic saline diuresis. Kidney Int. 20 (1981) 700-704
109. Rodriguez-Soriano J., Vallo A., Oliveros R., and Castillo G. Transient pseudohypoaldosteronism secondary to obstructive uropathy in infancy. J. Pediatr. 103 (1983) 375-380
110. Rosler A. The natural history of salt-wasting disorders of adrenal and renal origin. J. Clin. Endocrinol. Metab. 59 (1984) 689-700
111. Rosler A., Levine L.S., Schneider B., Novogroder M., and New M.I. The interrelationship of sodium balance, plasma renin activity, and ACTH in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 45 (1977) 500-512
112. Russell D.W., and White P.C. Four is not more than two. Am. J. Hum. Genet. 57 (1995) 1002-1005
113. Rutherford J.C., Stowasser M., Tunny T.J., Klemm S.A., and Gordon R.D. Laparoscopic adrenalectomy. World J. Surg. 20 (1996) 758-760
114. Saenger P., Levine L.S., Irvine W.J., Gottesdiener K., Rauh W., Sonino N., Chow D., and New M.I. Progressive adrenal failure in polyglandular autoimmune disease. J. Clin. Endocrinol. Metab. 54 (1982) 863-867
115. Sato A., and Funder J.W. High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 137 (1996) 4145-4153
116. Schembelan M., and Sebastian A. Hyporeninemic hypoaldosteronism. Adv. Intern. Med. 24 (1979) 385-405
117. Sequeira S.J., and McKenna T.J. Chlorbutol, a new inhibitor of aldosterone biosynthesis identified during examination of heparin effect on aldosterone production. J. Clin. Endocrinol. Metab. 63 (1986) 780-784
118. Sheppard K.E., and Funder J.W. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: Direct binding studies. J. Steroid Biochem. 28 (1987) 737-742
119. Sheppard K.E., and Funder J.W. Type I receptors in parotid, colon, and pituitary are aldosterone selective in vivo. Am. J. Physiol. 253 (1987) E467-E471
120. Shimkets R.A., Warnock D.G., Bositis C.M., Nelson-Williams C., Hansson J.H., Schambelan M., Gill Jr. J.R., Ulick S., Milora R.V., Findling J.W., et al. Liddle's syndrome: Heritable human hypertension caused by mutations in the β-subunit of the epithelial sodium channel. Cell 79 (1994) 407-414
121. Shuper A., Eisenstein B., Stark H., and Varsano I. Hyporeninemic hypoaldosteronism in a child with lactic acidosis, deafness, and mental retardation. J. Pediatr. 100 (1982) 769-772
122. Sowers J.R., Beck F.W., Waters B.K., Barrett J.D., and Welch B.G. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism. J. Clin. Endocrinol. Metab. 61 (1985) 60-67
123. Stewart P.M., Wallace A.M., Valentino R., Burt D., Shackleton C.H., and Edwards C.R. Mineralocorticoid activity of liquorice: 11β-Hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2 (1987) 821-824
124. Stockigt J.R., Topliss D.J., and Hewett M.J. High-renin hypertension in necrotizing vasculitis. N. Engl. J. Med. 300 (1979) 1218
125. Stowasser M., Gordon R.D., Klemm S.A., and Tunny T.J. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis. J. Clin. Endocrinol. Metab. 77 (1993) 800-804
126. Stowasser M., Gordon R.D., Tunny T.J., Klemm S.A., Finn W.L., and Krek A.L. Familial hyperaldosteronism type II: Five families with a new variety of primary hyperaldosteronism. Clin. Exp. Pharmacol. Physiol. 19 (1992) 319-322
127. Strautnieks S.S., Thompson R.J., Hanukoglu A., Dillon M.J., Hanukoglu I., Kuhnle U., Secki J., Gardiner R.M., and Chung E. Localisation of pseudohypoaldosteronism genes to chromosome 16p12.2-13.11 and 12p13.1-pter by homozygosity mapping. Hum. Mol. Genet. 5 (1996) 293-299
128. Streeten D.H.P., Tomycz N., and Anderson Jr. G.H. Reliability of screening methods for the diagnosis of primary aldosteronism. Am. J. Med. 67 (1979) 403-413
129. Sun Y., Ratajska A., Zhou G., and Weber K.T. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J. Lab. Clin. Med. 122 (1993) 395-403
130. Sutherland D.J.A., Ruse J.L., and Laidlaw J.C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95 (1966) 1109-1119
131. Suzuki Y., Nagashima T., Nomura Y., Onigata K., Nagashima K., and Morikawa A. A new compound heterozygous mutation (W17X, 436 + 5G -T) in the cytochrome P450c17 gene causes 17 alpha-hydroxylase/17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 199-202
132. Swain A., Narvaex V., Burgoyne P., Camerino G., and Lovell-Badge R. DAX-1 antagonizes Sry action in mammalian sex differentiation. Nature 391 (1998) 761-767
133. Tan S.Y., Shapiro R., Franco R., Stockard H., and Mulrow P.J. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann. Intern. Med. 90 (1979) 783-785
134. Taylor W., Carroll D., and Bethwaite P. Adrenal carcinoma presenting as Conn's syndrome. Aust. N. Z. J. Med. 27 (1997) 201-202
135. Taymans S.E., Pack S., Pak E., Torpy D.J., Zhuang Z., and Stratakis C.A. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J. Clin. Endocrinol. Metab. 83 (1988) 1033-1036
136. Thomas J.P. Aldosterone deficiency in a patient with idiopathic haemochromatosis. Clin. Endocrinol. (Oxf. 21 (1984) 271-277
137. Torpy D.J., Gordon R.D., and Stratakis C.A. Linkage analysis of familial hyperaldosteronism type II-Absence of linkage to the gene encoding the angiotensin II receptor type 1. J. Clin. Endocrinol. Metab. 83 (1998) 1046
138. Torpy D.J., Gordon R.D., Lin J.-P., Huggard P.R., Taymans S.E., Stowasser M., Chrousos G.P., and Stratakis C.A. Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J. Clin. Endocrinol. Metab. 83 (1998) 3214-3218
139. Ulick S., Blumenfeld J.D., Atlas S.A., Wang J.Z., and Vaughan Jr. E.D. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 76 (1993) 873-878
140. Uribarri J., Oh M.S., Butt K.M.H., and Carroll H.J. Pseudohypoaldosteronism following kidney transplantation. Nephron 31 (1982) 368-370
141. Veldhuis J.D., and Melby J.C. Isolated aldosterone deficiency in man: Acquired and inborn errors in the biosynthesis or action of aldosterone. Endocr. Rev. 2 (1981) 495-517
142. Veldhuis J.D., Kulin H.E., Santen R.J., Wilson T.E., and Melby J.C. Inborn error in the terminal step of aldosterone biosynthesis. Corticosterone methyl oxidase type II deficiency in a North American pedigree. N. Engl. J. Med. 303 (1980) 117-121
143. Weisnagel S.J., Gagner M., Breton G., Pomp A., Pharand D., and Lacroix A. Laparoscopic adrenalectomy. The Endocrinologist 6 (1996) 169-178
144. White P.C., Curnow K.M., and Pascoe L. Disorders of steroid 11β-hydroxylase isozymes. Endocr. Rev. 15 (1994) 421-438
145. White P.C. Abnormalities of aldosterone synthesis and action in children. Curr. Opin. Pediatr. 9 (1997) 424-430
146. White P.C., New M.I., and Dupont B. Congenital adrenal hyperplasia. Parts I and II. N. Engl. J. Med. 316 (1987) 1519-1524 ; 316, 1580-1586
147. Williams Jr. F.A., Schambelan M., Bigliero E.G., and Carey R.M. Acquired primary hypoaldosteronism due to an isolated zona glomerulosa defect. N. Engl. J. Med. 309 (1983) 1623-1627
148. Wilson M., Morganti A.A., Zervoudakis I., Letcher R.L., Romney B.M., Von Oeyon P., Papera S., Sealey J.E., and Laragh J.H. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am. J. Med. 68 (1980) 97-104
149. Young Jr. W.F. Primary hyperaldosteronism: Update on diagnosis and treatment. The Endocrinologist 7 (1997) 213-221
150. Young Jr. W.F., and Hogan M.J. Renin-independent hypermineralocorticoidism. Trends Endocrinol. Metab. 5 (1994) 97-106
151. Young Jr. W.F., and Klee G.G. Primary aldosteronism: Diagnostic evaluation. Endocrinol. Metab. Clin. North Am. 17 (1988) 367-395
152. Zachmann M., Tassinari D., and Prader A. Clinical and biochemical variations of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. A study of 25 patients. J. Clin. Endocrinol. Metab. 56 (1983) 222-229
153. Zadik Z., Kahana L., Kaufman H., Benderli A., and Hochberg Z. Salt loss in hypertensive form of congenital adrenal hyperplasia (11-beta-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 58 (1984) 384-387
154. Zanaria E., Muscatelli F., Bardoni B., Strom T.M., Guioli S., Guo W., Lalli E., Moser C., Walker A.P., McCabe E.R., et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372 (1994) 635-641
155. Zennaro M.C., Borensztein P., Jeunemaitre X., Armanini D., and Soubrier F. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 79 (1994) 32-38
156. Zipser R.D., Davenport M.W., Martin K.L., Tuck M.L., Warner N.E., Swinney R.R., Davis C.L., and Horton R. Hyperreninemic hypoaldosteronism in the critically ill: A new entity. J. Clin. Endocrinol. Metab. 53 (1981) 867-873